(IN THE MIDDLE OF THINGS): U.S. CHEMICAL INDUSTRY 2010 - 2011 Grace th IN MEDIA RES SPRING 2011 IN MEDIA RES Matthews, Inc. 219 North Milwaukee Street, 7 Floor Milwaukee, Wisconsin 53202 414.278.1120 gracematthews.com 1 IN MEDIA RES SPRING 2011 IN MEDIA RES SPRING 2011 GRACE MATTHEWS CHEMICAL PRACTICE Grace Matthews’ chemical investment banking group provides merger, acquisition, and corporate finance advisory services for basic and specialty chemical manufacturers worldwide. WWW.GRACEMATTHEWS.COM JOHN BEAGLE MANAGING DIRECTOR JBEAGLE@GRACEMATTHEWS.COM BENJAMIN SCHARFF DIRECTOR BSCHARFF@GRACEMATTHEWS.COM THOMAS C. OSBORNE SENIOR EXECUTIVE TOSBORNE@GRACEMATTHEWS.COM KEVIN YTTRE VICE PRESIDENT KYTTRE@GRACEMATTHEWS.COM ANDREW HINZ VICE PRESIDENT AHINZ@GRACEMATTHEWS.COM TRENT MYERS VICE PRESIDENT TMYERS@GRACEMATTHEWS.COM ANDREA WOLF ASSOCIATE AWOLF@GRACEMATTHEWS.COM Grace Matthews’ chemical investment banking practice is global in scope and well-known for its strong track record of successful chemical industry transactions dating back to the early 1990s. We have direct ties to chemical industry leaders worldwide, and have completed transactions with such companies as Akzo Nobel, 3M, DuPont, Sherwin-Williams, PPG Industries, Ashland, Ceradyne, DSM, ICI, Borregaard, Air Products, Landec Corporation, The Home Depot, Hexion Specialty Chemicals, Atofina Chemicals, Brush Engineered Materials, Becker Industrial Coatings, RPM International, Courtaulds, Domino Sugar, and Chr. Hansen Laboratories, as well as many of the world’s leading private equity firms. Grace Matthews’ three main practice areas are sell-side transactions (private companies, divestitures for large multi-national corporations and private equity owned businesses); buy-side projects (typically for major multi-nationals); and financing, where we raise debt and/or equity capital to support private equity sponsored management buy-outs or recapitalizations. AARON POLLOCK ANALYST APOLLOCK@GRACEMATTHEWS.COM CONTACT INFORMATION GRACE MATTHEWS, INC. 219 NORTH MILWAUKEE STREET 7TH FLOOR MILWAUKEE, WI 53202 P: 414.278.1120 F: 414.278.1119 WWW.GRACEMATTHEWS.COM INFO@GRACEMATTHEWS.COM 2 IN MEDIA RES SPRING 2011 CONTENTS 3 KEY TAKEAWAYS IN MEDIA RES THE REBOUND THE GRACE MATTHEWS CHEMICAL INDEX 4 U.S. CHEMICAL INDUSTRY: A GRAPHICAL OVERVIEW 5 IN MEDIA RES (IN THE MIDDLE OF THINGS): U.S. CHEMICAL INDUSTRY 2010 - 2011 6 THE REBOUND CHEMICAL M&A 2010 - 2011 2010 - 2011 CHEMICAL INDUSTRY SELECTED TRANSACTIONS 16 THE GRACE MATTHEWS CHEMICAL INDEX: VALUATIONS OF PUBLICLY TRADED CHEMICAL FIRMS 23 GRACE MATTHEWS SPECIALTY CHEMICAL TEAM 27 GRACE MATTHEWS RECENT CHEMICAL TRANSACTIONS 28 IN MEDIA RES SPRING 2011 KEY TAKEAWAYS IN MEDIA RES There was a pause in the economic recovery mid-way through 2010, but improving economic indicators in the fall provided evidence that a sustainable recovery is underway. Significant risks that remain include high levels of sovereign and consumer debt, high unemployment, burdensome regulation, and weakness in the housing market. There is a possibility of new asset bubbles resulting from the Federal Reserve’s monetary policy. Rising prices in commodities, common stocks and U.S. farm land indicate either that asset bubbles may be forming or significant inflation is ahead. Uncertainty over the economic outlook will act as a constraint on new investment and dampen the speed of recovery. Chemical manufacturers have strong balance sheets and the means to invest in new assets, but they will be reluctant to do so as long as they have excess capacity and there is anemic “pull through” demand in the end markets. A slow growth economy means that top line growth for chemical companies is going to be restrained, and that the robust profit growth we have seen over the past two years will eventually fade and begin to track GDP growth. THE REBOUND Led by strategic acquirers, chemical M&A rebounded strongly in 2010 after a lackluster 2008 and 2009. Financial buyers began to return to the markets in the second half of 2010, as their access to credit continued to improve. There have been a few large strategic deals, but the focus seems to be more on small or midsize “bolt-on” transactions. The M&A environment in 2011 looks very strong, with high-quality assets coming to market and generating competition between strategic and financial buyers. THE GRACE MATTHEWS CHEMICAL INDEX The Grace Matthews Chemical Index tracks the earnings and valuation multiples of 40 publically traded chemical firms and segments data by market size and industry groups. Valuations of chemical firms are value tilted, with lower multiples of earnings and book value than growth industries such as healthcare, technology, and media. Chemical valuations began to fall as the U.S. entered the recession, though earnings continued to climb for another year. The recession affected the valuations of chemical companies disproportionately, with smaller firms’ multiples declining more than larger, more diversified companies. Earnings multiples have shown a classic “V” shaped recovery since the spring of 2009, with valuations increasing faster than earnings because of the anticipation of robust earnings growth going forward. Recovering from a mid-year downturn in 2010, equity markets now appear to be pricing in a robust future profit cycle. 4 IN MEDIA RES SPRING 2011 U.S. CHEMICAL INDUSTRY A GRAPHICAL OVERVIEW ENTERPRISE VALUE/EBITDA RAILCAR LOADINGS U.S. Chemical Industry Enterprise Value/EBITDA: January 2005 – January 2011 U.S. Chemical Railcar Loadings: December 2009 – February 2011 Large Cap Mid Cap Small Cap Micro Cap 35,000 30,000 9.5 25,000 8.5 20,000 7.5 15,000 6.5 10,000 5.5 5,000 4.5 - 3.5 Source: American Association of Railroads Source: Grace Matthews, Inc. REVENUES CHEMICAL INDUSTRY PPI Chemical Industry Value of Shipments: January 2008 – January 2011 Producer Price Index: January 2008 – December 2010 70,000 250 240 230 220 210 200 190 180 65,000 60,000 55,000 50,000 45,000 Source: U.S. Census Bureau Source: Bureau of Labor Statistics PRODUCTION AND CAPACITY TRENDS INVENTORIES Chemical Production and Capacity Utilization: January 2008 – January 2011 Ratio of Chemical Industry Inventories to Shipments: January 2008 – January 2011 102 100 98 96 94 92 90 88 86 84 82 80 Production (Left Axis) Source: Federal Reserve Board 5 Capacity Utilization (Right Axis) 80% 78% 76% 74% 72% 70% 68% 66% 64% 62% 1.40 1.35 1.30 1.25 1.20 1.15 1.10 1.05 1.00 Source: U.S. Census Bureau IN MEDIA RES SPRING 2011 IN MEDIA RES (IN THE MIDDLE OF THINGS) THE ECONOMY AND THE CHEMICAL INDUSTRY 2010 - 2011 Economics is often called the “dismal science”: a term that originated in the 19th century in response to the writings of Thomas Malthus, who famously predicted that unchecked population growth would ultimately lead to mass starvation. Of course, Malthus could not have been more wrong, but the term has persisted, probably because economics may be the most inexact of the social sciences, and economic “forecasts” that predict the end of civilization tend to be the ones that actually get the public’s attention. At any one time, there are so many competing forecasts out there that usually at least one is going to turn out to be correct, if only because of the laws of probability. So when an economist accurately predicts an economic crisis, they become rock stars, sought after for appearances on CNBC and Bloomberg, and virtually guaranteed big advances on their next book. So it was with Nouriel Roubini and Meredith Whitney in predicting the onset of the subprime/financial crisis of 2008, and before them Robert Shiller in predicting the bursting of the tech stock bubble in 2000. Notwithstanding the obvious intelligence of these economists, we will never truly know if they had some special insight that eluded so many others, or if their number simply came up; that is, they had the “right” idea at the “right” time. If it hadn’t been them, it would have been someone else. Thinking about it this way probably doesn’t give them the credit they deserve, but it does serve as a reminder that getting it right once is no guarantee that they can do again. Those who remember the stock market crash of 1987 may remember Elaine Garzarelli, who as an analyst at Shearson Lehman Brothers called the crash a week before it occurred. As head of her own consulting firm in 2003, and just prior to the beginning of the 2003-2007 bull market, she predicted "a stock market stuck in a holding pattern for years.”1 Figure 1: S&P 500 January 2010 – March 2011 1350 1300 1250 1200 1150 1100 1050 1000 Source: Standard & Poors 1 BusinessWeek, March 24, 2003 6 IN MEDIA RES SPRING 2011 It’s especially important now to keep this in mind, because ever since the recovery began in the spring of 2009, there have been any number of compelling and conflicting scenarios for the future of the U.S. economy. Can we expect a continuing recovery or double-dip recession? A stronger or weaker dollar? Is significant inflation inevitable? Or should we worry about deflation instead? It hasn’t helped that the federal government’s response to the economic crisis has had few historical precedents, or that scheduled releases of economic data are too eagerly anticipated by legions of analysts, all wanting to be the first to see the new pattern, and who conveniently forget that the real trend is visible only in retrospect. Our collective indecision about the direction of the economy is reflected clearly in the performance of the stock market. (Figure 1) At the beginning of 2010, the markets continued the steady advance that would last for more than a year since the bottom in March 2009, with the S&P 500 finally closing over 1200 in April 2010. After that it was a bumpier ride, with big down moves in May-June (-11.0%) and August (-4.0%) interrupted by a big up move in July, (+9.5%), before a steady drumbeat of good economic reports (along with a big assist from the Fed’s QE2 policy) resulted in a sustained rally that began in September and which continues today. The markets’ bipolar mood swings are really evident in the VIX, the CBOE Volatility Index.2 (Figure 2) In late spring of 2010, the VIX reversed an 18 month downtrend and spiked upwards in response to the European sovereign debt crisis, first in Greece and then in Ireland. The VIX settled back to a range between the teens and low 20s in the fall as the stock market continued its advance and the economy continued to improve. It’s surprising that the recent uprisings in the Middle East and the Japanese Tsunami/Nuclear Crisis have not caused another spike in VIX, but so far there has been Figure 2: VIX Index (CBOE Volatility Index) January 2008 – March 2011 100 90 80 70 60 50 40 30 20 10 0 Source: Chicago Board Options Exchange The VIX is a measure of the expected of volatility of the S&P 500 index over the next 30 days, and is based on the volatility expressed in index put and call options. Although the VIX is sometimes called the "fear index", high values are not necessarily bearish. The VIX really measures the inherent risk of the market, such that high readings only mean investors expect that the market soon will move sharply in either direction. 2 7 IN MEDIA RES SPRING 2011 only a modest uptick to the mid-20s. This could change if the situation in the Middle East or Japan takes an unexpected turn, and oil prices rise above $125 per barrel, a level that many economists believe could cause the recovery to stall. Spikes in the VIX continue to remind us that optimism about the recovery should be tempered by an awareness of “tail” risk: events - often geo-political which cannot be predicted and which deliver an unanticipated shock to the economy. Figure 3: Chemical Industry Value of Shipments January 2008 – January 2011 70,000 65,000 60,000 55,000 50,000 45,000 Source: U.S. Census Bureau As would be expected, the chemical industry reflects what’s going on in the broader economy. Chemical firms reported strong revenues and earnings in the last half of 2009 and the first quarter of 2010. (Figure 3) Higher pricing, moderate energy costs, and the return of more “normalized” patterns of demand were factors, but the industry deserves credit for how well it managed through the recession. Layoffs and plant closures may have been painful, but they enabled many companies to emerge from the recession stronger than when they entered it. With leaner staffing and the higher efficiency of retained capacity, chemical firms had high levels of operating leverage, so that even modest upticks in demand translated into bottom line profits. This was exactly where a company wanted to be in the early phase of the recovery. In the first half of 2010, chemical companies reported continued growth in revenues and earnings, with revenues hitting an 18 month high in April before tapering off over the summer. In reporting second quarter earnings, some firms warned that the second half might not be as robust as the first. Specialty chemicals manufacturers in particular reported that rising raw material prices and lingering weakness in the housing markets might constrain full year profits. Over the summer, there were anecdotal reports that demand in many end markets was softening. Figure 4: US Railcar Loadings of Chemicals January 2007 – January 2011 40000 35000 Trendline 30000 25000 20000 15000 10000 5000 0 Trendline In fact, unit volume demand had been softening since the beginning of the year: U.S. railcar loadings of chemicals and the Federal Reserve’s Chemical Production Index show that the growth curve of the industry began to flatten out as early as January. The long term trend in railcar loadings, evident since the beginning of 2009, is steady and upward, though the pace (slope) of the uptrend is more gradual than Source: American Association of Railroads 8 IN MEDIA RES SPRING 2011 we would prefer. (Figure 4) But if you take a closer look at the near term data, you see that railcar loadings were basically flat for all of 2010, crossing the 30,000 unit threshold only four times. (Figure 5) Industrial production and capacity utilization of chemicals also reached post-recession highs in January 2010, before entering a slump that lasted until August. (Figure 6) Figure 5: US Railcar Loadings of Chemicals 35,000 December 2009 – February 2011 30,000 25,000 20,000 15,000 10,000 5,000 - The leveling off in the chemical Source: American Association of Railroads industry predated a broader slowdown in the economy that began sometime in the second quarter. Total U.S. industrial production turned flat in July 2010 and remained so until November, but the Chemical Production Index turned negative six months earlier and was growing again by August. (Figure 7) After growing at a 3.7% rate in the first quarter of 2010, GDP grew at an annualized rate of only 1.7% in second quarter, 2.6% in the third, and 2.8% in the fourth. Late in the third quarter, and through the end of the year, the situation began to improve. Virtually all of the broad economic and chemical industry indicators turned around, and seemed to suggest that the economy at last was on a sustainable, albeit slow, growth path. Predictions of softer profits in the chemical industry in the second half of the year never materialized. The S&P Chemical Index, after hitting a mid-year low of 220.77 on July 6, rose 47.4% to 325.41 by March 3, 2011. (Figure 8) In retrospect, the cause of the mid-year slump appears obvious. When Greece nearly defaulted on its sovereign debt in the late spring of 2010, many believed it would be the first domino among the heavily indebted “PIGS” (Portugal, Ireland, Greece and Spain) to go down. And with their debt denominated in Euros, the whole Figure 6: Chemical Production and Capacity Utilization Eurozone was threatened, even January 2008 – January 2011 healthy countries like Germany. 102 80% Though the immediate crisis 100 78% 98 passed by the fall, many investors 76% Production 96 and economists began to have (Left Axis) 74% 94 second thoughts over the summer 72% 92 about whether the global 90 70% Capacity Utilization 88 (Right Axis) financial crisis was really over. 68% We don’t discount the importance of the sovereign debt issue, and we have more to say on it below, but we also believe there were other factors domestically that contributed to the slump in the U.S. The first year or so of the 9 86 84 82 80 Source: Federal Reserve Board 66% 64% 62% IN MEDIA RES SPRING 2011 recovery was a period when the Figure 7: Total Industrial & Chemical Production Indexes main drivers of growth were January 2007 – January 2011 inventory restocking and public Total Industrial Production Chemical Production (i.e., government) initiatives: 102.5 stimulus spending and tax incentives designed to direct 97.5 consumer spending to ailing industries like autos and housing. 92.5 By nature, these things were 87.5 temporary, and as their effect began to fade, a slowdown in 82.5 growth should have been expected. The period we are in now is one of transition, where the challenge is to replace those Source: Bureau of Labor Statistics temporary stimuli with private sector sources of growth that are more permanent and sustainable. That will be difficult, as will be described below. For the immediate future, there are two headwinds to growth: unemployment and weakness in housing. Longer term, we will have to come to terms with excess levels of government debt, which, unless we can bring it under control, is more likely than not to be the cause of the next recession, two to five years out. Regarding unemployment, it may appear to many that the difference between this recovery and a lingering recession is so slight that it’s as much as matter of personal perspective as it is of economic analysis. In other words, if you have a job, it’s a recovery; if you don’t, it’s a recession. Although the idea of a “jobless recovery” may be a cliché, consider that at the beginning of the recovery in March 2009, unemployment stood at 8.5%, and it only climbed from there, reaching a peak of 10.2% in October 2009. Unemployment was above 9.5% for all but one month in 2010, and Figure 8: S&P Chemical Index January 2010 – March 2011 340 320 300 280 260 240 220 200 Source: Standard & Poors 10 IN MEDIA RES SPRING 2011 only recently, more than three years after the recession began, does it finally appear to be trending downward.3 (Figure 9) In March 2011, unemployment was 8.9%; by contrast, in the wake of the 2001-2002 recession, unemployment peaked at 6.3%. With so many consumers overleveraged and unemployed, the return of robust “pull through” demand from discretionary spending may be a long time coming. Figure 9: Unemployment Rates January 2008 – January 2011 12% 10% 8% 6% 4% 2% 0% The government doesn’t appear to have many options to alleviate unemployment. After the Republican gains in the mid-term Source: Bureau of Labor Statistics elections, another stimulus package is out of the question. Indeed, the focus for both parties now has shifted to how much of the federal budget can be cut. With fiscal stimulus out of the picture, monetary policy, the province of the Federal Reserve, has been the government’s only option in attempting to jump start the economy and reduce unemployment. Quantitative Easing, or “QE2” in its current incarnation, is the Fed’s policy of purchasing treasury bonds using newly printed dollars. By increasing the money supply, the Fed hopes to keep interest rates low, ward off the threat of deflation, and increase exports through a weakened dollar. In the first round of Quantitative Easing, between December 2008 and March 2010, the Fed purchased $1.7 trillion in short-term Treasuries and mortgage-backed bonds, and is credited with preventing a recurrence of the Great Depression. In QE2, announced last August Interest rates are not really the problem. and implemented at the beginning of November, the Fed plans to purchase $600 billion in long-term Even with rates at record lows, Treasuries. businesses are not going to borrow to fund new investments as long as there is insufficient demand to support new capacity. Now that we’re over halfway through the program, how has it worked? In our view, it’s been like pushing on a string. Not only has it been ineffective, but it may be doing more harm than good. The Fed can have only an indirect influence on long-term interest rates, and since the policy was implemented, intermediate and long-term Treasury rates have actually been rising: the yield on the 10-year Treasury is currently more than 100 basis points higher since October. But interest rates are not really the problem. Even with rates at record lows, businesses are not going to borrow to fund new investments that would create new private sector jobs as long as there is insufficient demand in the end markets to support new capacity. “Insufficient demand” of course just means consumer spending is too low, which itself is partially a function of the level of employment. It appears that we are stuck for the moment in a negative feedback loop, for which unfortunately time may be the only cure, no matter how well intentioned the Fed’s efforts have been. After each of the previous two recessions, in early 1990s and early 2000s, employment gains lagged increases in GDP. The recession was dated by the Business Cycle Dating Committee of the National Bureau of Economic Research, which determined that the recession began in December 2007 and ended in June 2009. 3 11 IN MEDIA RES SPRING 2011 The real controversy relating to QE2, the one that has so many conservative economists and politicians worried, is that it may unleash inflation, which once out of the box, may turn out to be beyond the Fed’s capacity to control. To an extent, the Fed wants some level of inflation, if only to head off the worse prospect of deflation. But with so much “slack” in wages and manufacturing capacity, a rapid increase in the money supply is less likely to raise the overall price level than it is to cause some degree of “asset inflation” or, to take a less charitable view of the situation, “asset bubbles.”4 In a weakened economy with no capacity to absorb it, all that extra cash has to find a home somewhere. And so it has, in the prices of U.S. farm land, precious metals, commodities, and common stocks.5 (Figure 10) Everyone is familiar with the stock market’s almost unbroken ascent since last fall, and everyone is equally aware that the prices of nearly any commodity you care to name has also been rising. Some have even speculated that rising food prices may have played a role in the recent uprisings in the Middle East. While there are some fundamentals that support rising prices, large increases in asset prices over a short period suggest that excess liquidity could also be at work, and that bubbles may be forming. As we all know from recent experience, asset bubbles tend to end badly. The Fed’s focus on “core” inflation, which excludes food and energy prices, may obscure a broader trend of growing inflationary pressures. Figure 10: Dow Jones UBS Commodity Index Government efforts to support the recovery are also going to be 180 constrained by the continuing 170 difficulties in the housing market. 160 It’s not clear that home values 150 140 have hit bottom; the widely 130 watched Case-Schiller Index 120 suggests that the housing market is 110 already in a double-dip recession. After declining throughout 20082009, home prices began rising in Source: UBS Securities, LLC and Dow Jones & Company Inc. 2010, but in the fourth quarter began falling again, with home values declining 4.1% year-over-year.6 Declining home values not only depress consumer spending, but also negatively impact employment growth. An unemployed homeowner with an “underwater” mortgage is twice disadvantaged: without substantial savings (which most do not have), not only are they unable to refinance, they can’t move to take a job in an area with better employment opportunities. The imbalances in the housing market took a long time to develop, and they are going to take a long time to unwind. January 2010 – March 2011 To be fair to Chairman Bernanke and the Federal Reserve, it’s likely that asset inflation is to some extent a secondary, though unstated, goal of QE2. Their hope is that inflating the value of financial assets will create a “wealth effect” that will stimulate consumer spending. 4 5 It’s ironic that in the wake of Great Recession, as commercial and residential real estate values are still well below 20062007 levels, the prices of prime Midwestern U.S. farm land are appreciating at double digit rates, and according to the President of the Kansas City Federal Reserve, may be entering bubble territory. See Statement of Thomas M. Hoenig, President Federal Reserve Bank of Kansas City, Before the Senate Committee on Agriculture, Nutrition, and Forestry, United States Senate, February 17, 2011. 6 National Home Prices Are Close to the 2009Q1 Trough According to the S&P/Case-Shiller Home Price Indices, Press Release, S&P Indices, February 22, 2011. 12 IN MEDIA RES SPRING 2011 Longer term, economic growth is going to be constrained by the threat posed by large government deficits and high levels of national debt in the United States and Europe. Just as the Greek sovereign debt “crisis” of last spring faded from the headlines, the European Union had to put together a bailout package for the former “Celtic Tiger” Ireland. The situation in Greece and Ireland had the effect of exposing just how weak the finances of many of the EU countries really were, as investors and the financial press turned their attention to the shaky condition of other EU nations, first Portugal, then Spain, and then to a lesser extent, Belgium and Italy. The story is still developing: in early March, Moody’s downgraded Spain’s debt, and the EU finance ministers met to discuss additional rescue packages that may be needed by Portugal and Greece.7 This should not be a surprise. For over a year, the International Monetary Fund (IMF), in a reversal of its traditional role of providing tough love to third-world countries that get into trouble, has warned that the spillover from the financial crisis means that it’s the sovereign debt in developed nations that now threatens the global economy.8 A loss of confidence in the ability of any one of the EU governments or its leading banks to pay interest or refinance debt could lead to a downward spiral. As borrowing costs increase in both the public and private sectors, economic activity would decline. In turn, government revenues would fall, further eroding the creditworthiness of the government’s debt, ultimately forcing it to cut spending on a massive scale, including much beloved entitlements and social programs. Such a scenario is playing out in Ireland now: it entered a recession in 2008, with its GDP declining 8% in 2009 and 1.6% in 2010. After accepting the EU bailout package, the government instituted a harsh four-year austerity plan designed to cut $20 billion from its budget. Putting this in perspective, Ireland’s annual government revenues are less than $70 billion and its GDP is less than $180 billion.9 What would happen if the crisis spreads to other European countries? Ireland and Portugal may be only the 38th and 36th largest economies in the world, respectively, but Spain is ranked 9 th, and Italy is 7th.10 A sharp rise in oil prices or inflation resulting from on-going regime change in the Middle East could be just the economic shock needed to trigger the next stage in Europe’s sovereign debt crisis. It’s probable that the European financial crisis affected the fall elections in the U.S., as voters looked to Europe and increasingly saw the future of the American economy. “Tea Party” candidates and mainstream Republicans made the national debt their issue, and were rewarded at the polls. Going into 2011, the national conversation on our debt has acquired a new urgency. With federal stimulus money now gone, newly elected governors are aggressively cutting expenses in states where a balanced budget is mandated by the state constitution. As the confrontation between the public unions and the Governor of Wisconsin made clear, the budgeting process has the potential of forcing painful choices and further polarizing an already divided electorate. The drama that occurred in Wisconsin in early 2011 may be a harbinger of a struggle that will soon play out on the national stage. It’s clear that the federal government ultimately will be forced to act, since its ability to continue rolling over our rapidly growing debt at historically low rates inevitably will end. This reckoning may be approaching soon. According to the IMF, between 2011 and 2013, the U.S., along with a number of EU countries and Japan, will face a “wall” of maturing 7 Andreas Calas, Why Moody’s Downgraded Spain’s Debt Ratios, Christian Science Monitor, March 11, 2011. International Monetary Fund, Global Financial Stability Report, April 2010, pp. 3-11. 9 CIA Factbook, 2011. 10 Ranked by nominal GDP for 2009. International Monetary Fund, World Economic Outlook Database, October 2010. 8 13 IN MEDIA RES SPRING 2011 debt that will need to be refinanced. Competition among nations to refinance this debt, as well as competition resulting from the funding needs of emerging economies, could force up interest rates and derail the global recovery. For years, investors and countries with excess reserves accepted lower rates because inflation was low, but a tipping point may come when the risk of holding sovereign debt outweighs its relatively meager total return potential. At that point, bond investors are going to demand higher risk premiums, and rolling over national debt is going to become a much more expensive proposition. In the United States, as in most countries, the choices will be stark: cut spending, raise taxes, or both. For chemical producers, there are two implications of a slower growth, and riskier, economy. First, top and bottom line growth from existing operations will be restrained. The benefits from increased operating efficiencies developed during the recession will cease to drive profit growth, and both revenues and profits will begin to more closely follow the growth track of GDP. Additionally, without significant growth in end market demand, companies that have large cash balances simply will not be able to find good investment opportunities in which to deploy capital that would drive incremental revenue growth. Instead, they are more likely to pursue acquisitions. As discussed in the following article “The Rebound”, the deal environment strengthened in 2010 and looks very strong in 2011. Second, we believe public and private market valuations will have to readjust to reflect slower earnings growth. The period of multiple expansion that typically follows a recession may be coming to an end, but it’s not clear whether earnings multiples – Price/Earnings and Enterprise Value/EBITDA ratios – have found a level that reflects the realities of the post-recession environment. As the following article on public valuations of chemical companies shows, multiples have come back and are at near pre-recession levels, mainly because valuations (the numerator in valuation ratios) have increased faster than earnings (the denominator). Multiple expansion should level off as earnings growth slows. Managing risk in the supply chain, particularly for firms whose raw materials are derivatives of crude oil, is another emerging issue for chemical firms. Oil, so deeply embedded in the economy, is different from all other commodities in that it is not renewable (you can always plant a new crop of wheat) and it is too often at the Figure 11: Chemicals Price Producer Index vs. Price of Crude Oil center of global politics. January 2000 – January 2011 $160 Price of Crude Oil Chemical PPI $140 260 240 $120 $100 Chemical PPI (Right Axis) $80 220 200 $60 180 $40 $20 $- Source: Bureau of Labor Statistics Price of Crude Oil (Left Axis) 160 140 The chemical industry always has been heavily dependent on oil, either for energy, a source of raw materials, or both. Though chemical prices generally do not exhibit the same volatility as crude oil, the cost of chemical production generally has tracked changes in the prices of crude oil, meaning that the chemical industry is vulnerable to the same geo-political considerations that affect worldwide oil production. (Figure 11) In 2008, a spike in the 14 IN MEDIA RES SPRING 2011 Chemicals Producer Price Index (PPI) accompanied the crude oil “bubble” that formed in the spring and summer. When the bubble collapsed in the fall, chemical production costs also fell, but then resumed a long-term uptrend, reaching a new record high in January 2011. From September through December 2010, the price of crude increased 27%, from about $71.25 a barrel to over $90.50 a barrel by the end of the year. To an extent, the increase was a function of the improving economy, though many believe that the rising price of oil, along with the prices of other commodities, was a sign of incipient inflation resulting from Fed’s loose monetary policy (QE2). But the increase in the price of oil in the fall of 2010 turned out to be just a prelude. After the governments of Tunisia and Egypt were brought down by popular uprisings, many believed that the Middle East was about to undergo the experience of Eastern Europe after the fall of the Soviet Union, as demands for democratic reforms spread to Bahrain, Yemen, Iran, Iraq and Saudi Arabia. But the developments in Libya showed that peaceful transitions of power are not always a given. At this writing, Libya is mired in a brutal civil war, and there’s a real possibility that it will eventually end up more like Somalia than Egypt. Though Libya may account for only about 2% of world oil production, the oil markets have priced in this risk, with the cost of oil shooting up from $92 per barrel at the beginning of January to over $105 per barrel by March 7th, a 15% increase. The economic “shock” of rising oil prices is already reflected in the rising costs of raw materials for chemical manufacturers. Depending upon their end markets, and where their products lie on the commodities/specialties continuum, chemical firms have varying capabilities to pass through price changes in the cost of petrochemicals and other raw materials, though usually with a lag that can range from weeks to months. During periods of rapidly escalating prices, producers usually can’t raise prices fast enough to offset declining margins, and when the costs of raw materials fall, they are reluctant to cut prices as they attempt to recapture lost margin. All producers suffer from the increased price volatility that can accompany rapid change in the geo-political environment. For public firms, quarter-to-quarter margin predictability is a key driver of market capitalization. Smaller, generally private firms do not have this problem, but in some respects they have it even tougher: without the advantages of scale, they lack pricing power with customers and leverage with suppliers, and have more difficulty accessing alternate sources of supply. Both public and private firms have to invest more in working capital just to be able to adjust to price fluctuations. Thus it appears that the industry is at an inflection point. We have emerged from the recession, and the “rebound” phase of the recovery is probably coming to an end. Whatever is coming next is not that clear, especially since so many risks to the global economy remain unresolved. What is certain is that there will be spillover into the chemical industry from developments in the world at large, and that some of these developments will be unforeseen and difficult to manage. But the industry proved in 2008 and 2009 that it is capable of adapting to even the most unpredictable environments, and it’s probably inevitable that within a year or so, the markets will have settled and the industry will have a better idea of where we’re headed. 15 CHEMICAL M&A 2010 - 2011 The deep wounds left from the Great Recession are starting to heal and recovery is underway credit markets are thawing and cash-rich chemical firms are looking for ways to accelerate growth. In 2010, chemical transactions totaled $36 billion, 44% higher than the aggregate total deal volume of $25 billion for all of 2009.1 The acceleration in M&A activity in 2010 is even more remarkable given that the 2009 number was inflated by the value of one transaction: Dow Chemical’s $15.5 billion purchase of Rohm & Haas which accounted for about 62% of total deal value. In the first half of 2010, strategic buyers clearly dominated the M&A market while financial buyers, hampered by limited access to financing, accounted for only 6% of total transaction value. However, as the credit markets improved, financial buyers began to return to the markets in force, with one noteworthy example being Bain Capital’s $1.6 billion acquisition of Dow’s Styron business in March 2010. With lots of cash to be invested, financial investors have considerable pent-up demand, and with financing becoming easier to obtain, private equity groups are once again hunting for quality assets.2 While there were a Figure 1: Large Strategic Chemical Deals 2010 - 2011 handful of large Buyer Target Date Value strategic deals that Berkshire Hathaway Lubrizol Pending $9.7 billion closed in 2010 or have DuPont Danisco Pending $6.3 billion been announced in Süd-Chemie (controlling Clariant Pending $2.8 billion 2011, these types of stake) deals seem to be more DSM Martek Pending $1.1 billion the exception than the CF Industries Terra Industries April 2010 $4.7 billion rule. Though the December BASF Cognis $4.0 billion 2010 chemical industry Mitsubishi Chemical Mitsubishi Rayon March 2010 $2.5 billion seems to be rebounding globally, Bain Capital Dow’s Styron business June 2010 $1.6 billion there are a number of Akzo Nobel’s National Corn Products October 2010 $1.3 billion Starch factors that threaten the sustainability and speed of the recovery. The housing and automotive markets, key markets for chemicals, are still well below pre-crisis levels. Additionally, the continuing sovereign debt crisis in Europe, political unrest in the Middle East, the drying up of government stimulus dollars, persistent high levels of unemployment, aggressive government regulatory pressures and concerns related to rising feedstock prices all pose a threat to recovery and make it less likely that chemical strategics will want to “bet big” on large deals in the near future. There are strong strategic rationales for the large deals that have closed or are pending. Corn Products’ $1.3 billion acquisition of National Starch from Akzo Nobel filled out Corn Products’ ingredients portfolio and is expected to be accretive to earnings by the end of 2011. BASF’s $4.0 Estimated by Young & Partners, New York, counting transactions with a value greater than $25 million. The Blackstone Group estimates that private equity groups have over $500 billion to invest, higher than the $463 billion available in 2007 at the previous peak in private equity cycle. See Vincent Valk, “Banker: “Golden Years” Coming for Private Equity”, Chemical Week, January 20, 2011. 1 2 16 IN MEDIA RES SPRING 2011 THE REBOUND IN MEDIA RES SPRING 2011 billion (€3.1 billion) purchase of Cognis will provide BASF with a stronger position in the more economically resilient personal care markets. Finally, DuPont’s pending acquisition of Danisco will advance Dupont’s position in the health and nutrition markets. What may turn out to be the biggest deal of 2011 is neither strategic nor private equity. In midMarch, Berkshire Hathaway announced that it will acquire Lubrizol for $9.7 billion in an all cash deal. At $135/share, the price represented a 28% premium over the stock price the day prior to the announcement. Though Berkshire does own a number of chemical assets, including Benjamin Moore Paints, there are no real synergies between Lubrizol and other Berkshire companies. Instead, Berkshire’s chairman and CEO Warren Buffet - as in most of his acquisitions just saw an old fashioned value play in Lubrizol: “Lubrizol is exactly the sort of company with which we love to partner - the global leader in several market applications run by a talented CEO, James Hambrick," said Buffett.3 The chemical M&A “sweet-spot” in 2011 is likely to be small- to mid-size “bolt-on” deals with values less than $500 million. Bolt-on acquisitions, where a target company has a particularly strong strategic fit and could be easily integrated into the acquiring company’s operations, allow companies to upgrade technology, expand their market capabilities, and/or deepen their product portfolios. Additionally, with continuing uncertainty over the direction of the global economy, bolt-on acquisitions represent a clear, low-risk approach to growth. That this approach would be the course of choice for strategics emerging from the recession was made clear by a number of industry CEOs in conference calls during 2010.4 An excellent example of a recent bolt-on is Eastman Chemicals’ purchase of Genovique Specialties in May 2010. The acquisition strengthened Eastman’s existing plasticizers and intermediates product lines, and enhanced its diversification into emerging geographic regions. Solutia completed a number of bolt-on acquisitions in 2010 including its $304 million acquisition of Etimex Solar (Germany) in June and a $73 million purchase of Novomatrix (Singapore) in May. Both acquisitions extended Solutia's reach in performance materials for the renewable energy (Etimex Solar) and aftermarket window films (Novomatrix) markets. And it appears Solutia’s bolton acquisition strategy isn’t set to stop anytime soon. In an article published in September 2010, CEO Jeffry Quinn was quoted as saying “We’re looking for highly synergistic bolt-on acquisitions much like Etimex Solar and Novomatrix.”5 Lubrizol Press Release, March 14, 2011. See also: “Why Warren Buffett Just Spent $10 Billion”, The Wall Street Journal. March 18, 2011. 4 In PPG’s first quarter 2010 earnings call, CEO Charles Bunch stated “We intend to further deploy our strong cash position focused on bolt- on acquisitions and share repurchases to fuel our earnings growth.…” Similarly, in Lubrizol’s first quarter 2010 earnings call, CEO James Hambrick, said “…our desire is to make several high-quality bolt-on acquisitions in the $100 million to $500 million range.” Lastly, in Dow Chemical’s fourth quarter 2010 earnings call, CEO Andrew Liveris stated “the bolt-on M&A….there will be some of that as we go through. But these are high margin bolt-ons, ones where we can maybe buy small regionally and scale up globally so we can get synergies immediately.” 5 ICIS, September 2010, Solutia CEO Interview 3 17 Buyer Target Date PPG Industries Equa-Chlor Pending PPG Industries Bariun Chemical Pending Valspar Isocoat Tintas e Vernizes Ltda. February 2011 Lubrizol Nalco’s Performance Products Business ITW Celeste Industries Eastman Chemical Genovique Specialties Solutia Etimex Solar Solutia Novamatrix Arkema Dow’s UCAR Emulsion Systems Braskem Sunoco’s Polypropylene Business Valspar Wattyl’s Australian Deco Sherwin-Williams Arch Industrial Wood Coatings Altana Aquaprint Akzo Nobel Lindgens Metal Decorating Coatings and Inks Stepan Alfa Systems Landec Warburg Pincus’ Lifecore January 2011 January 2011 May 2010 June 2010 May 2010 January 2010 January 2010 June 2010 March 2010 April 2010 July 2010 July 2010 April 2010 Comments PPG will gain a strategic foothold in the western US chlor-alkali markets Strengthens PPG’s leadership position in the Chinese and Asian packaging coatings industry Strengthens Valspar’s presence in Latin America and broadens its range of technologies for general industrial applications Expands Lubrizol's Noveon® personal care and household care product portfolio Broadens ITW’s line of transportation chemicals Adds volume and reach for Eastman’s plasticizers business Positions Solutia as a worldwide one-stop shop for encapsulants used in solar energy applications Enhances Solutia’s performance materials for the windows aftermarket Strengthens Arkema’s acrylics product line and becomes the core of a new emulsions business unit Builds on the consolidation of petrochemical assets to make Braskem a leading North and South American producer of petrochemicals Strengthens Valspar’s position in Asia Pacific region and expands its brand portfolio Builds on Sherwin Williams’s position as a leading global supplier of wood coatings Adds to Altana’s capabilities in coatings and varnishes for printing applications Consolidates Akzo’s position as a leading global supplier of packaging coatings Increases Stepan’s polyester polyol capacity in Europe Expands Landec’s capabilities in advanced materials to include biomaterials Potential “bolt-on” companies coming to market are not expected to be in short supply. Over the past few years, many large chemical firms have undertaken restructuring efforts that have resulted in a number of quality businesses coming to market. Dow Chemical’s sale of its UCAR Emulsions Systems business to Arkema in January 2010 is a perfect example. The sale supported Dow’s strategy of focusing more on downstream specialty products, as well as helped pay down the debt it took on as a result of the Rohm & Haas transaction. For Arkema, the business fits easily into its existing acrylics business, and formed the core of a new Emulsion Systems unit focused on the coatings, adhesives and construction products markets. Additional deal flow is coming from private equity, as many private equity funds postponed the divestiture of portfolio companies during the recession and are likely to put these businesses on the market in the near-term. Many private companies also were brought to market in 2010 by shareholders who anticipated changes in the tax code relating to capital gains. This was especially significant in the second half of 2010, and we now expect this to be a driver of M&A activity in 2011-2012 as well, since Congress and the President reached an agreement in December 2010 to extend the Bush tax cuts for two years. In 2011, we expect to see a continuing high level of M&A activity. Organic growth for strategics is going to be difficult due to slow pace of the recovery. In the absence of home grown 18 IN MEDIA RES SPRING 2011 Figure 2: 2010 - 2011 “Bolt-Ons” IN MEDIA RES SPRING 2011 investment opportunities, the logical choice will be to grow through acquisitions, especially for companies with strong earnings and healthy balance sheets. Additionally, large chemical companies will continue to divest non-core assets. Many of these firms would have preferred to shed these assets during the downturn, but were not able to sell due to the shortage of buyers and lack of liquidity. With improved market conditions and rising valuations, strategics will likely revisit putting these non-core assets on the market. Private equity interest in chemical transactions is also expected to be high as financial buyers seek to place capital. With many high-quality companies coming to market now, and with banks again willing to lend to profitable and well-managed companies, competition in the market should be strong for the remainder of the year. It will be a good environment for sellers, who can expect to get pricing and terms very close to what they could have received prior to the recession. 19 DATE ACQUIRER TARGET Pending Berkshire Hathaway Lubrizol Pending PPG Industries Equa-Chlor Pending Clariant Süd-Chemie (controlling stake) Pending DuPont Danisco Pending China National Bluestar Orkla’s Elkmen business (Oslo) Pending Evonik Boehringer Ingelheim’s RESOMER® brand polymers for medical and pharmaceutical applications Pending AXA Private Equity (Paris) Novacap (majority stake) Pending Mexichem Rockwood Holdings’ AlphaGary’s plastic compounding business Pending Perstorp Ashland’s pentaerythritol business Pending Novozymes Merck KGaA’s Crop BioScience subsidiary Pending DSM Martek Biosciences Pending TSRC (Taipei) Dexco Polymers (Dow Chemical/ExxonMobil 50/50 JV) Pending Olin PolyOne’s 50% interest in the SunBelt Chlor-Alkali partnership Pending H.I.G Capital Cytec’s Building Block Chemicals business Pending PPG Industries Bairun Chemical Pending Univar Quaron Group Pending Mexichem Ineos’ Fluor unit Feb-11 DAK Americas Eastman’s PET business Feb-11 Valspar Isocoat Tintas e Vernizes Ltda., (São Paulo, Brazil) Jan-11 Lubrizol Nalco’s performance products business Jan-11 Hallstar Biochemica International Jan-11 Lanxess Darmex (Buenos Aires) Jan-11 Pinova Holdings LyondellBasell’s flavors and fragrances business Jan-11 Quaker Summit Lubricants Jan-11 PolyOne Uniplen Industria de Polimeros Jan-11 BASF SHELL’S Styrene Catalyst Business Jan-11 K+S Potash One (majority stake) 20 IN MEDIA RES SPRING 2011 2010 - 2011 CHEMICAL INDUSTRY SELECTED TRANSACTIONS IN MEDIA RES SPRING 2011 DATE ACQUIRER TARGET Jan-11 ITW Celeste Industries Jan-11 Blackstone Capital Partners Polymer Group, Inc. Dec-10 Univar BCS Dec-10 TPG Capital Ashland Distribution Dec-10 BASF Cognis Dec-10 HEXPOL Excel Polymers Nov-10 Caltius Equity Partners National Industrial Coatings, Inc. (Nicoat) Nov-10 Rhodia Feixiang Chemicals Nov-10 Arsenal Capital Partners Royal Adhesives and Sealants (Quad-C) Nov-10 Clayton, Dubilier & Rice Univar (CVC Capital Partners) Nov-10 American Securities Arizona Chemical (Rhone Capital) Oct-10 Univar Basic Chemical Solutions Sep-10 Dayton Superior Unitex Chemicals Sep-10 ITW Panreac (3i) Sep-10 Akzo Nobel Changzhou Prime Automotive Paint Sep-10 Sherwin-Williams Becker Acroma Sep-10 New Mountain Capital Mallinckrodt Baker Sep-10 IGM Resins Cognis’ UV Acrylates business Jul-10 Stepan Alfa Systems Jul-10 Akzo Nobel Lindgens Metal Decorating Coatings and Inks Jul-10 Brenntag EAC Industrial Ingredients Jul-10 Vantage Specialty Chemicals Lipo Chemicals Jun-10 Valspar Wattyl’s Australian Deco Jun-10 Bain Capital Dow Chemical’s Styron Jun-10 Flint Group Torda Jun-10 Harren Equity Partners Marianna Industries Jun-10 Solutia Entimex Solar Jun-10 OCI DSM’s fertilizer and melamine businesses 21 ACQUIRER TARGET Jun-10 RPM Hummer Voll Industrial May-10 Solutia Novomatrix May-10 Surfin Chemicals/Aterian Investment Partners Chemtura’s PVC additives business May-10 A. Schulman ICO May-10 KLK Emmerich Croda’s German Oleochemicals business May-10 Eastman Chemical Genovique Specialties Apr-10 Nalco Res-Kem Apr-10 Nalco General Water Services Apr-10 Landec Warburg Pincus’ Lifecore Apr-10 Jarden Corp. Total’s Mapa Spontex business Apr-10 Braskem Quattor Apr-10 Evonik Arkema’s methacrylate esters business Apr-10 Altana Aquaprint Mar-10 Mitsubishi Chemical Mitsubishi Rayon Mar-10 Sherwin-Williams Arch Chemical’s Industrial Wood Coatings Mar-10 KMG Chemicals General Chemical’s electronic chemicals business Mar-10 RPM Chemtec Chemicals Mar-10 A. Schulman McCann Color Mar -10 H.B. Fuller Revertex Finewaters Mar-10 Sika Henkel Japan’s construction sealant business Mar-10 3M MTI PolyFab Mar-10 Aceto Andrews Paper & Chemical Mar-10 Evonik H.C. Starck’s catalyst unit Feb-10 OM Group EaglePicher Technologies Feb-10 Kiri Dyes and Chemicals Dystar Textilfarben Jan-10 Braskem Sunoco Chemicals’ polypropylene business Jan-10 Zep Amrep Jan-10 Arkema Dow Chemical’s UCAR Emulsions Systems business IN MEDIA RES SPRING 2011 DATE 22 IN MEDIA RES SPRING 2011 THE GRACE MATTHEWS INDEX VALUATIONS OF PUBLICLY TRADED CHEMICAL FIRMS The Grace Matthews’ Chemical Valuation Index is comprised of 40 publicly traded chemical companies, spanning multiple markets, geographies, and company sizes. The Index aggregates financial data from quarterly reports, and tracks valuation trends across different market capitalization ranges and industry sectors. At any point in time, the Index calculates average valuations for public chemical companies, highlighting key differences between the averages and specific companies or industry groups. The Index tracks historical trends in revenue and earnings multiples, as well as other profitability and solvency ratios. Studying the Index in the context of historical data tracking the S&P 500, private equity fund flows, and economic fundamentals reveals the relationship between the chemical industry and the overall market environment. Historically, the chemical industry is value tilted, with lower price/earnings and price/book ratios than growth industries such as technology, healthcare, and media. Between 2005 and 2011, average valuation multiples for the Index have been 1.1X revenues and 7.8X EBITDA. Figure 1: Grace Matthews Chemical Index: Mean Values January 2011 Sales Revenue EBITDA Enterprise Value EV/Revenues EV/EBITDA Micro Cap Index Small Cap Index Mid Cap Index Large Cap Index Full Index (in millions) (in millions) (in millions) (in millions) (in millions) $752 $55 $509 $2,355 $272 $2,098 $36,874 $6,397 $57,058 $11,529 $1,905 $16,949 1.1 9.2 0.9 7.6 1.7 9.3 1.2 8.4 Aceto Corp. Brush Engineered Materials Ceradyne Darling International Lifeway Foods Quaker Chemical Spartech A.Schulman Zep, Inc. Arch Chemicals Corn Products International Cytec Industries H.B. Fuller Ferro Georgia Gulf OM Group PolyOne Corp. RPM International Sensient Technologies $5,479 $771 $6,488 1.4 8.8 Ashland Chemicals Avery Dennison Corp Church and Dwight Eastman FMC Corp Huntsman International Flavors & Fragrances Lubrizol Sherwin Williams Valspar Archer Daniels Midland Air Products BASF Clorox Co. DuPont De Nemours Dow Chemical Ecolab 3M Company Proctor and Gamble PPG Industries Source: Grace Matthews, Inc. 2007 – 2010: FROM PEAK TO TROUGH AND BACK As is the case with other suppliers of basic materials to the economy, chemical companies’ growth and valuations tend to move in parallel with domestic GDP growth. It’s now well understood that the stock market highs attained in the fall of 2007 were unsupported by the underlying environment of financial excess, deteriorating corporate profits, and softening real estate values. Chemical market valuations began to decline in the fall of 2007 as the recession began, even as industry earnings continued to expand for another year.6 (Figure 2) A typical experience for the time is represented by Sherwin-Williams, a diversified coatings manufacturer. The National Bureau of Economic Research (NBER), the organization responsible for dating recessions and expansions, has determined that the recession began in September 2007 and ended in June 2009. 6 23 IN MEDIA RES SPRING 2011 Sherwin-Williams’ net income rose 6.8% in 2008, yet its stock price declined nearly 13% during the same period. Figure 2: Enterprise Value and EBITDA January 2005 – January 2011 EBITDA 2500 Enterprise Value 5000 EBITDA Enterprise Value 4500 As the recession deepened, 2000 4000 chemical companies faced an 3500 environment of vastly increased 1500 3000 capacity and stagnating 2500 demand. By early 2009, 1000 2000 capacity utilization for the 1500 chemical industry had fallen to 500 1000 500 all-time lows, as many 0 0 companies were forced to shut manufacturing facilities or scale back production. As is common during recessions, large Source: Grace Matthews, Inc. diversified chemical companies survived by going lean, raising cash, and laying off workers. The recession had the effect of accelerating a long-standing trend of declining employment in the U.S. chemical industry, due to automation, increasing labor productivity, and offshoring. (Figure 3) Small chemical companies’ valuations got hit much harder than their large-cap counterparts in 2008 and 2009. Compared with large multinationals, smaller firms entered the recession with less ability to squeeze out fixed costs, higher default risks, and capital structure constraints. Chemical companies with market capitalizations below $500 million lost on average over 69% of their total market capitalization from peak to trough, compared to 49% for companies larger than $10 billion. Enterprise Value/EBITDA ratios for micro cap companies fell below 4.5X in early 2009 compared to 7.5X for large cap Figure 3: U.S. Chemical Industry Employment chemical conglomerates.7 January 2000 – January 2011 1000 (in thousands) 950 900 850 800 750 Source: Grace Matthews, Inc. A classic “V” shaped economic recovery, beginning in the third quarter of 2009, is ostensibly shown by the performance of industry multiples in the wake of the Great Recession. From April 2009 to January 2011, Enterprise Value/EBITDA ratios increased from 6.7X to 9.3X for large caps. The recovery for micro caps was more dramatic: over the same period, Enterprise Value/EBITDA ratios more than doubled, from 4.0X to 9.2X. (Figure 4) 7 “Enterprise Value”, or “EV”, is the sum of all invested capital in a company, including both the value of equity (market capitalization) and funded debt. The EV/EBITDA ratio is similar to the classic P/E ratio, but it eliminates the effect that a company’s capital structure will have on the ratio, therefore allowing direct comparisons between different companies. When M&A professionals speak of “multiples”, they are usually referring to EV/EBITDA multiples. 24 IN MEDIA RES SPRING 2011 2011 VALUATION AND GROWTH PROSPECTS Recovering from a mid-year downturn in 2010, equity markets now seem to be pricing in a robust future profit cycle. Aggregate earnings have started to eclipse the all-time highs of mid-2008, and corporate profits are steadily increasing as companies benefit from the operating leverage gained through cost cutting during the recession. Forecasts for the first quarter of 2011 appear to anticipate modest strength and measured improvement across the chemical value chain. Figure 4: Enterprise Value / EBITDA By Size January 2005 – January 2011 Large Cap Mid Cap Small Cap Micro Cap 9.5 8.5 7.5 6.5 5.5 4.5 3.5 Source: Grace Matthews, Inc. In the Grace Matthews Spring 2010 Chemical Whitepaper “Chemicals at the Crossroads” we discussed the importance of balance sheet strength for chemical companies, observing that relative to acquisitions, “those in the best position to move forward are the well-capitalized strategic buyers.” We believe that this is even more relevant now as cost cutting and a rebound in sales have resulted in companies having unprecedented levels of cash on their books. Net Debt to EBITDA (Funded debt less cash divided by EBITDA) has decreased 31% on average since February 2010. (Figure 5) It is our belief that M&A will continue to be strong in 2011 as public companies look to acquisitions as a way to deploy capital built up over the past year. Figure 5: Selected Chemical Company Valuations February 2010 vs. February 2011 February 2010 Net Debt / EBITDA Enterprise Values / Revenues (ttm) 3M 0.4 2.6 Akzo Nobel N.V. 1.0 0.9 Air Products & Chemicals, Inc. 2.0 Albemarle Corporation February 2011 Net Debt / EBITDA Enterprise Value/ Revenues (ttm) 9.8 0.2 2.4 9.1 7.2 1.3 0.9 7.4 2.6 10.5 1.6 2.5 9.6 1.6 1.2 12.8 0.6 2.3 10.3 Ashland Inc. 1.6 0.5 5.6 1.0 0.6 7.1 BASF Corporation 1.5 0.9 5.9 1.0 1.1 5.4 The Dow Chemical Company 5.2 1.2 16.1 3.1 1.2 9.4 Cytec Industries, Inc. 2.3 0.9 9.7 0.8 0.9 8.4 DuPont 2.3 1.4 10.8 1.5 1.8 9.9 Eastman Chemical Company 1.3 1.0 7.9 0.8 1.2 6.5 H.B. Fuller Co. 0.7 0.9 7.6 0.8 0.9 8.4 The Lubrizol Corporation 0.6 1.4 7.0 0.4 1.6 7.2 NA* 0.8 5.2 0.2 1.0 8.4 PPG Industries, Inc. 1.9 1.0 9.1 1.2 1.2 8.7 RPM International 1.4 0.9 7.7 1.5 1.1 9.0 The Sherwin-Williams Company 0.7 1.1 8.8 1.1 1.3 10.8 Sensient Technologies Corp. 2.2 1.5 8.8 1.6 1.5 9.5 The Valspar Corporation 1.7 1.2 8.4 1.4 1.4 9.2 W.R. Grace & Co. 0.4 0.6 5.9 NA* 0.9 6.3 Median 1.6 1.0 8.4 1.1 1.2 8.7 Mean 1.6 1.2 8.7 1.1 1.4 8.5 Olin Corporation *Cash balance exceeds debt 25 Enterprise Value / EBITDA (ttm) Enterprise Value/EBITDA (ttm) IN MEDIA RES SPRING 2011 As the unrest in the Middle East and the Japanese Tsunami have shown, 2011 will not be without its setbacks, and the long-term effects of such events on the global recovery and public company valuations are as yet unknown. Disregarding this risk and looking purely at the financial issues, it appears that in the near term a weak U.S. dollar will help chemical companies that export goods or earn revenues abroad, and that chemical valuations will be supported by improving economic fundamentals. This conclusion appears to be supported by the modest improvement in valuation multiples over the past six months. 26 IN MEDIA RES SPRING 2011 GRACE MATTHEWS SPECIALTY CHEMICAL TEAM: STRONG COMMITMENT TO CHEMICALS John Beagle Managing Director & Chemical Team Leader jbeagle@gracematthews.com Kevin Yttre Vice President kyttre@gracematthews.com Ben Scharff Director bscharff@gracematthews.com Andrew Hinz Vice President ahinz@gracematthews.com Thomas Osborne Senior Executive tosborne@gracematthews.com Andrea Wolf Associate awolf@gracematthews.com Trent Myers Vice President tmyers@gracematthews.com 27 Aaron Pollock Analyst apollock@gracematthews.com has acquired has sold its portfolio company merged with from Beckers Industrial Coatings has acquired the stock of to Grace Matthews, Inc. advised Landec Corporation on this transaction Grace Matthews, Inc. advised Brockway Moran on this transaction has sold its Resilient Floor Coatings Business to has acquired Grace Matthews, Inc. advised LORD Corporation on this transaction Grace Matthews, Inc. advised Akzo Nobel nv on this transaction Grace Matthews, Inc. advised ColorMatrix Corporation on this transaction Grace Matthews, Inc. advised NorthStar Chemicals, Inc. on this transaction has acquired has sold its specialty chemical subsidiary has acquired has acquired Grace Matthews, Inc. advised Minco on this transaction Grace Matthews, Inc. advised Company Akzo Nobel nv on this transaction Grace Matthews, Inc. advised Columbia Paint & Coatings on this transaction has been recapitalized by Grace Matthews, Inc. advised Specialty Coatings Company on this transaction has acquired to The Flood Grace Matthews, Inc. advised Northwest Coatings, LLC on this transaction Corporation has been acquired by Grace Matthews, Inc. advised Landec Corporation on this transaction Facilitator Capital has sold theFund stock of has acquired the assets of to Grace Matthews, Inc. advised Raabe Corporation on this transaction has sold the assets of Lubrizol Performance Systems to Grace Matthews, Inc. advised Lubrizol Corporation on this transaction Grace Matthews, Inc. advised the shareholders of CERAC, Inc. on this transaction has licensed exclusive fields of Intelimer technology from Grace Matthews, Inc. advised Pacific Epoxy Polymers, Inc. on this transaction has been acquired by a subsidiary of Grace Matthews, Inc. advised Landec Corporation on this transaction Grace Matthews, Inc. advised GSI General Materials, LLC on this transaction has acquired certain assets of the Foam Latex operations, located in Calhoun, GA, of Grace Matthews, Inc. advised Bostik Findley, Inc. on this transaction has sold its U.S. fine chemicals subsidiary, Borregaard Synthesis, Inc., to Grace Matthews, Inc. advised Borregaard on this transaction 28 IN MEDIA RES SPRING 2011 SELECT GRACE MATTHEWS CHEMICAL TRANSACTIONS IN MEDIA RES SPRING 2011 219 North Milwaukee Street, 7th Floor Milwaukee, WI 53202 29 414.278.1120 www.gracematthews.com info@gracematthews.com